Medical Ophthalmological Society

Medical Ophthalmological Society (UK)

Austin Court, IET Birmingham

17 March 2011, 09.00 17.00

Convenor: Prof Paul Dodson
09.00 - 09.25Registration and Coffee
09.25 - 09.30WelcomeDr Eoin Sullivan
9.30 - 11.00Session 1
Symposium Diabetic Macular Oedema
Chair Dr Deborah Broadbent
09.30 - 09.45Management of systemic risk factorsProf Paul Dodson
09.45 - 10.15What's new in laser, vitrectomy and steroids for DR - who needs anti VEGFs!Prof Jon Gibson
10.15 - 10.45We do? - the case for anti-VEGFsProf Michael Ip
10.45 - 11.00Discussion
11.00 - 11.30Coffee     
11.30 - 12.30Session 2
Update on Stroke
Chair Dr Liz Graham
Prof Graham Venables
12.30 - 13.30Lunch (MOSUK committee and scientific meeting)     
13.30 - 15.30Session 3
Original Presentations
Chair Dr John Olson
13.30 - 13.42How accurate are surrogate markers used to detect macular oedema in the ENSPDRH Wharton
13.42 - 13.54An audit and review of temporal artery biopsies in NHS Grampian June December 2010J McKee
13.54 - 14.06Obstructive sleep apnoea and sight threatening retinopathy: a novel association in patients with type 2 diabetesA Tahrani
14.06 - 14.18Moyamoya disease presenting to the ophthalmology ClinicM Williams
14.18 - 14.30Management and outcome of cholesterol embolus identified in a DR screening programmeK Whitehouse
14.30 - 14.42Alcohol induced Retinal Pigment Epitheliopathy - a new entity?D Verma
14.42 - 14.54A fatal case of Aspergillus endocarditis presenting as fungal endophthalmitisW Innes
14.54 - 15.06Use of Intravitreal Avastin in treatment of Radiation induced optic neuropathyM Abushaala
15.06 - 15.18An audit of the fast-track referral pathway for retinal arterial embolic disease in BristolE Damato
15.18 - 15.30A complex case of choroiditisS Epps
15.30 - 15.38Survival of Patients with Rheumatoid Arthritis associated corneal disease undergoing Corneal TransplantA Stylianides
15.38 - 16.00Tea     
16.00 - 17.00MOS(UK) Annual Lecture
Visuo-vestibular interaction: Clinical and Research aspects
Chair Dr Simon Hickman
Mr Barry Seemungal

This meeting has been supported with an educational grant from Novartis UK.